CE marking is essential for the marketing of medical devices within the European Union (EU). It certifies that the product complies with the safety, health and environmental protection requirements laid down by the EU. This article details the process for obtaining CE marking, the obligations of manufacturers and the implications for medical devices.
CE marking is a compulsory certification for many medical devices marketed in the European Union. It indicates that the manufacturer has assessed its product and found it to comply with EU health and safety requirements. It is essential for manufacturers around the world to comply with these standards if they are to gain access to the European market.
All medical devices intended to be marketed in the EU must bear the CE mark, regardless of whether they are manufactured inside or outside the EU. This includes devices of all classes (I, IIa, IIb and III), with a few exceptions, such as devices used in clinical investigations.
For Class IIa, IIb and III devices, assessment by a notified body is required. These bodies are independent entities designated by EU Member States to assess the conformity of medical devices. Their identification number must accompany the CE marking on the product.
Once a device has been placed on the market, manufacturers must monitor its performance and safety. This includes setting up a post-marketing surveillance system and reporting incidents to the competent authorities.
The marketing of medical devices without CE marking or which do not comply with the requirements may result in sanctions, including withdrawal of the product from the European market.
CE marking is a crucial step in accessing the European market for medical devices. It guarantees that products meet EU safety and performance standards, thereby ensuring the protection of patients and users.